The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action - PubMed

Affiliations

• PMID: 25997382
• DOI: 10.1017/S0007114515001452

Free article

Review

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action

W M A D B Fernando et al. Br J Nutr. 2015.

Free article

Abstract

Coconut, Cocos nucifera L., is a tree that is cultivated to provide a large number of products, although it is mainly grown for its nutritional and medicinal values. Coconut oil, derived from the coconut fruit, has been recognised historically as containing high levels of saturated fat; however, closer scrutiny suggests that coconut should be regarded more favourably. Unlike most other dietary fats that are high in long-chain fatty acids, coconut oil comprises medium-chain fatty acids (MCFA). MCFA are unique in that they are easily absorbed and metabolised by the liver, and can be converted to ketones. Ketone bodies are an important alternative energy source in the brain, and may be beneficial to people developing or already with memory impairment, as in Alzheimer's disease (AD). Coconut is classified as a highly nutritious 'functional food'. It is rich in dietary fibre, vitamins and minerals; however, notably, evidence is mounting to support the concept that coconut may be beneficial in the treatment of obesity, dyslipidaemia, elevated LDL, insulin resistance and hypertension - these are the risk factors for CVD and type 2 diabetes, and also for AD. In addition, phenolic compounds and hormones (cytokinins) found in coconut may assist in preventing the aggregation of amyloid-β peptide, potentially inhibiting a key step in the pathogenesis of AD. The purpose of the present review was to explore the literature related to coconut, outlining the known mechanistic physiology, and to discuss the potential role of coconut supplementation as a therapeutic option in the prevention and management of AD.

Keywords: Alzheimer's; Amyloid; Coconut; Diabetes; Saturated fat.

Similar articles

• Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.

  Castro CB, Dias CB, Hillebrandt H, Sohrabi HR, Chatterjee P, Shah TM, Fuller SJ, Garg ML, Martins RN. Castro CB, et al. Nutr Rev. 2023 Aug 10;81(9):1144-1162. doi: 10.1093/nutrit/nuac104. Nutr Rev. 2023. PMID: 36633304

• Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease.

  Chatterjee P, Fernando M, Fernando B, Dias CB, Shah T, Silva R, Williams S, Pedrini S, Hillebrandt H, Goozee K, Barin E, Sohrabi HR, Garg M, Cunnane S, Martins RN. Chatterjee P, et al. Mech Ageing Dev. 2020 Mar;186:111209. doi: 10.1016/j.mad.2020.111209. Epub 2020 Jan 15. Mech Ageing Dev. 2020. PMID: 31953123 Review.

• Variability in coconut (Cocos nucifera L.) germplasm and hybrids for fatty acid profile of oil.

  Kumar SN. Kumar SN. J Agric Food Chem. 2011 Dec 28;59(24):13050-8. doi: 10.1021/jf203182d. Epub 2011 Dec 6. J Agric Food Chem. 2011. PMID: 22118628

• Coconut Milk and Coconut Oil: Their Manufacture Associated with Protein Functionality.

  Patil U, Benjakul S. Patil U, et al. J Food Sci. 2018 Aug;83(8):2019-2027. doi: 10.1111/1750-3841.14223. Epub 2018 Jul 13. J Food Sci. 2018. PMID: 30004125 Review.

Cited by

• Administration of Young Coconut (Cocos nucifera L.) Juice Ameliorates Memory Impairment in a Menopausal Rat Model.

  Sugiyama S, Matsushita H, Minami A, Nakao H, Hata S, Matsumoto A, Takeuchi H, Wakatsuki A. Sugiyama S, et al. Diseases. 2024 Oct 12;12(10):250. doi: 10.3390/diseases12100250. Diseases. 2024. PMID: 39452493 Free PMC article.

• Development and Sensory Assessment of Ready-to-Eat Breakfast Cereal.

  Frimpong TG, Wireko-Manu FD, Oduro I. Frimpong TG, et al. Int J Food Sci. 2022 Aug 12;2022:4566482. doi: 10.1155/2022/4566482. eCollection 2022. Int J Food Sci. 2022. PMID: 35990772 Free PMC article.

• Lauric Acid Alleviates Neuroinflammatory Responses by Activated Microglia: Involvement of the GPR40-Dependent Pathway.

  Nishimura Y, Moriyama M, Kawabe K, Satoh H, Takano K, Azuma YT, Nakamura Y. Nishimura Y, et al. Neurochem Res. 2018 Sep;43(9):1723-1735. doi: 10.1007/s11064-018-2587-7. Epub 2018 Jun 26. Neurochem Res. 2018. PMID: 29947014

• Guilingji capsule for Alzheimer's disease: secondary analysis of a randomized non-inferiority controlled trial.

  Ming Z, Yimiao L, Huichan W, Yu C, Lina MA, Hui P, Hao LI. Ming Z, et al. J Tradit Chin Med. 2023 Oct;43(5):1019-1025. doi: 10.19852/j.cnki.jtcm.20230404.006. J Tradit Chin Med. 2023. PMID: 37679990 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • CORE
  • Cambridge University Press
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information